Phase III study of the eastern cooperative oncology group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer Article

keywords

  • CARCINOMA
  • DOSE-ESCALATION
  • Life Sciences & Biomedicine
  • Oncology
  • RADIATION-THERAPY
  • SURVIVAL
  • Science & Technology
  • TRIAL

Location

  • Chicago, IL

Digital Object Identifier (DOI)

start page

  • 3760

end page

  • 3767

volume

  • 23

issue

  • 16